Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie W Lees

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|July 12, 2016
Bilateral lower limb weakness in acute severe ulcerative colitisRuairi W Lynch, Timothy Soane, Rod Gibson, et al.
Gastro Hep Advances|February 10, 2025
A Systematic Review and Meta-Analysis: Adverse Inflammatory Bowel Disease Outcomes Following Acute COVID-19Evangelin Shaloom Vitus, Simran Mann, Charlie W Lees, et al.
The Lancet. Gastroenterology & Hepatology|June 13, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' replyJames L Alexander, Nicholas A Kennedy, Charlie W Lees, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 9, 2020
Paediatric Patients (Less Than Age of 17 Years) Account for Less Than 1.5% of All Prevalent Inflammatory Bowel Disease CasesChristopher J Burgess, Paul Henderson, Gareth-Rhys Jones, et al.
Gastroenterology Report|February 23, 2026
Global patterns of disease progression in inflammatory bowel disease: a comprehensive synthesis of contemporary population-based cohortsBeatriz Gros, Carlos Frutos, Beatriz Carrillo Cubero, et al.
European Journal of Gastroenterology & Hepatology|October 1, 2019
Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's diseaseNikolas Plevris, Philip W Jenkinson, Ian D Arnott, et al.
Frontline Gastroenterology|December 17, 2021
Are we addressing the top 10 research priorities in IBD?Jeroen Geldof, Jean-Frédéric LeBlanc, Laura Lucaciu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2019
Association Between Level of Fecal Calprotectin and Progression of Crohn's DiseaseNicholas A Kennedy, Gareth-Rhys Jones, Nikolas Plevris, et al.
The American Journal of Gastroenterology|July 30, 2025
Inflammatory Bowel Disease and Risk of More than 1,500 Comorbidities: A Disease-wide Prediagnostic and Postdiagnostic Phenomic Association StudyAnthony C Ebert, Bram Verstockt, Martin Bøgsted, et al.
Advances in Therapy|July 31, 2023
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical ProgramMichael Chiorean, Marco Daperno, Charlie W Lees, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|July 12, 2016
Bilateral lower limb weakness in acute severe ulcerative colitisRuairi W Lynch, Timothy Soane, Rod Gibson, et al.
Gastro Hep Advances|February 10, 2025
A Systematic Review and Meta-Analysis: Adverse Inflammatory Bowel Disease Outcomes Following Acute COVID-19Evangelin Shaloom Vitus, Simran Mann, Charlie W Lees, et al.
The Lancet. Gastroenterology & Hepatology|June 13, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' replyJames L Alexander, Nicholas A Kennedy, Charlie W Lees, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 9, 2020
Paediatric Patients (Less Than Age of 17 Years) Account for Less Than 1.5% of All Prevalent Inflammatory Bowel Disease CasesChristopher J Burgess, Paul Henderson, Gareth-Rhys Jones, et al.
Gastroenterology Report|February 23, 2026
Global patterns of disease progression in inflammatory bowel disease: a comprehensive synthesis of contemporary population-based cohortsBeatriz Gros, Carlos Frutos, Beatriz Carrillo Cubero, et al.
European Journal of Gastroenterology & Hepatology|October 1, 2019
Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's diseaseNikolas Plevris, Philip W Jenkinson, Ian D Arnott, et al.
Frontline Gastroenterology|December 17, 2021
Are we addressing the top 10 research priorities in IBD?Jeroen Geldof, Jean-Frédéric LeBlanc, Laura Lucaciu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2019
Association Between Level of Fecal Calprotectin and Progression of Crohn's DiseaseNicholas A Kennedy, Gareth-Rhys Jones, Nikolas Plevris, et al.
The American Journal of Gastroenterology|July 30, 2025
Inflammatory Bowel Disease and Risk of More than 1,500 Comorbidities: A Disease-wide Prediagnostic and Postdiagnostic Phenomic Association StudyAnthony C Ebert, Bram Verstockt, Martin Bøgsted, et al.
Advances in Therapy|July 31, 2023
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical ProgramMichael Chiorean, Marco Daperno, Charlie W Lees, et al.
Pageof 10